Konrad Glund
6Patents
4h-index
12Co-inventors
43Inventor score
Filing activity: May 13, 1999 → Aug 9, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6548481B1 | Effectors of dipeptidyl peptidase IV | Chemistry; Metallurgy | 135 | Expired |
| US6500804B2 | Method for the improvement of islet signaling in diabetes mellitus and for its prevention | Human Necessities | 51 | Expired |
| US7053055B2 | Compounds of unstable DP IV-inhibitors | Human Necessities | 23 | Expired |
| US6890905B2 | Methods for improving islet signaling in diabetes mellitus and for its prevention | Human Necessities | 13 | Expired |
| US7368421B2 | Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis | Chemistry; Metallurgy | 1 | Expired |
| US6458568B1 | Method for the production of baccatin-III by enzymatic synthesis | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.